Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04QAE
|
||||
Former ID |
DIB012132
|
||||
Drug Name |
CXCR3 antagonists
|
||||
Synonyms |
CXCR3 antagonists (autoimmune disease); CXCR3 antagonists (autoimmune disease), Amgen
|
||||
Indication | Autoimmune diabetes [ICD10:E08-E13] | Investigative | [552115] | ||
Company |
Amgen Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
O=S1(=O)CCC(CN([C@@H](c2nc3ncccc3c(=O)n2c2ccc(cc2)Cl)C)<br />C(=O)Cc2ccc(C(F)(F)F)c(c2)F)CC1
|
||||
Target and Pathway | |||||
Target(s) | C-X-C chemokine receptor type 3 | Target Info | Antagonist | [543922] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | CXCR3-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.